Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.87 USD
Change Today +0.08 / 2.87%
Volume 681.0K
RIGL On Other Exchanges
As of 8:10 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Elliott B. Grossbard M.D.

Chief Medical Officer and Executive Vice President,Rigel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2014


Dr. Elliott B. Grossbard, MD, has been the Chief Medical Officer and Executive Vice President of Rigel Pharmaceuticals, Inc. since February 2008. Dr. Grossbard served as Senior Vice President of Medical Development at Rigel Pharmaceuticals, Inc. since April 2002. Dr. Grossbard served as Vice President of Clinical Affairs for Avigen Inc. Dr. Grossbard served as a Senior Vice President of Development and Vice President of Medical & Regulatory Affairs at Scios, Inc. where, ...

Read Full Background

Corporate Headquarters*

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships*

There is no Board Members Memberships data available.


Unknown/Other Education
Columbia University
Columbia University
Yale Law School
Columbia College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$521,339

Stock Options*

All Other Compensation$11,406
Exercisable Options1,018,125
Unexercisable Options271,875
Total Number of Options1,290,000

Total Compensation*

Total Annual Cash Compensation$532,745
Total Short Term Compensation$521,339
Other Long Term Compensation$11,406
Total Calculated Compensation$1,317,035
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RIGL:US $2.87 USD +0.08


Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer, President and Principal Financial Officer
Arena Pharmaceuticals, Inc.
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RIGEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at